HARMONY BIOSCIENCES HOLDINGS, INC. Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
HARMONY BIOSCIENCES HOLDINGS, INC. (HRMY) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of -$166.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2026-08-04
- HARMONY BIOSCIENCES HOLDINGS, INC. effective income tax rate reconciliation, other adjustments, amount for the quarter ending 2026-06-30 was -$166.00K.
- HARMONY BIOSCIENCES HOLDINGS, INC. effective income tax rate reconciliation, other adjustments, amount for fiscal 2025 was $1.10M.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 3 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 6 month | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month |
|---|---|---|---|
| 2026-06-30 | -$166.00K 10-Q · filed 2026-08-04 | -$166.00K 10-Q · filed 2026-08-04 | |
| 2025-12-31 | $1.10M 10-K · filed 2026-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |